KZA 0.00% 8.0¢ kazia therapeutics limited

Even Some Longs Dont Get It, page-6

  1. 6,852 Posts.
    lightbulb Created with Sketch. 2536
    From last years AACR Special Conference in Nov. JG said they are looking for partners what better partner than one that will benefit themselves....

    "Animals treated with Anisina/VCR showed a significant and profound regression of tumor growth compared to control and either drug treatment alone. Further to this, of the 5 animals in the combinatorial Anisina/VCR treatment group 3 (60%) reached a “complete response” with one animal showing a “maintained complete response” for more than 100 days post treatment. The outcomes of this study have significant therapeutic implications as microtubule inhibitors such as VCR are current standard of care for a wide range of solid tumors, including neuroblastoma."
    http://cancerres.aacrjournals.org/content/76/5_Supplement/B27
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.